Inspected by the FDA. No deviations from applicable federal regulations (no 483 issued).

Welcome to Asentral Institutional Review Board

The founders of Asentral, Inc. IRB have well over 100 combined years of direct experience in clinical research. Drawing from personal knowledge, they came together in 2001 and developed a common image of what a world-class IRB should look like and how it would operate. This image was based upon the premise that professional supervision, industry expertise, and uncompromising ethical standards can be combined to provide the highest level of human subject welfare for clinical research. Over the past decade of carefully controlled growth, these professionals have developed that image into one of the most client-focused and service oriented IRB's in the industry today.

GENERAL FACTS
  • Asentral, Inc. IRB is an independent, central IRB, incorporated in 2001
  • Audited by the FDA (not a "for-cause" audit) resulting in no Form 483 (report of non-compliances)
  • Selected by National Cancer Institute as a partner in the Cancer Trials Support Unit (CTSU) program
ADVANTAGES OF WORKING WITH ASENTRAL
  • Ready access to IRB meeting agendas
  • Weekly IRB meetings
  • 24-hour turnaround time on IRB decisions
  • Dedicated account managers assigned to each study
  • Personalized and professional attention
  • Thorough, professional IRB reviews performed by an experienced Board
  • Scientific members of Board are drawn from the hospitals and research universities of greater Boston
  • Unparalleled support
  • Customized training programs available for CRO, Sponsor, and/or Investigators